Abstract.
Patients with follicular lymphoma (FL) usually present with advanced disease, with lymph nodes and bone marrow involvement. Extranodal infiltration is infrequent. In FL isolated cutaneous relapse is a very rare event that, to the best of our knowledge, has not been previously reported. We report on a 55-year-old woman with FL who presented with an isolated skin relapse 5 years after the diagnosis. The patient, who had relapsed after three lines of chemotherapy, was treated with the chimeric anti-CD20 antibody, rituximab, achieving a complete response, which has now persisted for more than 24 months.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Ferrer, .A., López-Guillermo, .A., Montoto, .S. et al. Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab. Ann Hematol 80, 479–481 (2001). https://doi.org/10.1007/s002770100314
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002770100314